$0.0579
-0.00160-2.69%
At close: -
$0.0280
-0.03-51.64%
After Hours: Jan 27, 9:28 AM EDT
Comments
Loading...
Oncotelic Therapeutics Stock Guidance | OTC:OTLC | Benzinga
Oncotelic Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oncotelic Therapeutics Inc (OTLC) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Oncotelic Therapeutics (OTLC)?
There have been no specific sales or earnings guidance reported for Oncotelic Therapeutics in recent months.
Browse guidance and forecast on all stocks.
